![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Grünebach Frank Brossart Peter
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.15, Iss.12, 2005-12, pp. : 1703-1709
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells
By Boudier Ariane Aubert-Pouëssel Anne Gerardin Corine Devoisselle Jean-Marie Begu Sylvie Louis-Plence Pascale Quentin Julie Jorgensen Christian
Drug Development and Industrial Pharmacy, Vol. 35, Iss. 8, 2009-08 ,pp. :